Immunor
Chemicals & Related Products · Norway · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Gaustadalléen 21, Oslo, Oslo, 0349, Norw...Website
www.immunor.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Immunor
Immunor AS is a Norwegian-based vaccine developer specializing in peptide-based vaccine technologies, leveraging its unique Cell Penetrating Selective Peptide Vaccine Platform (CPSPVP). With over 25 years of experience, the company focuses on creating safe and efficacious vaccines, including candidates for Diabetes Type 1, Diabetes Type 2, various cancers, and HIV. Immunor's innovative approach has been validated during the Covid pandemic and is supported by partnerships with leading scientific institutions. The company aims to address global health challenges with its advanced vaccine solutions.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Immunor your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Immunor
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Immunor, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Immunor is spiking on competitors!
Earning: See what the market has to say on Immunor recently announced quarterly report
Check if Immunor has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Immunor launches new products
Funding: Get notified immidiatlly once Immunor has new funding data
Click to see if Immunor had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Immunor
Compare insights from companies similar to Immunor, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Immunor
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Immunor is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Immunor is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Immunor.
Immunor Tech Stack
A closer look at the technologies used by Immunor
Top Chemicals & Related Products Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Immunor
Sign Up For FreeTo access detailed company insights
Immunor AS is a Norwegian-based vaccine developer specializing in peptide-based vaccine technologies, leveraging its unique Cell Penetrating Selective Peptide Vaccine Platform (CPSPVP). With over 25 years of experience, the company focuses on creating safe and efficacious vaccines, including candidates for Diabetes Type 1, Diabetes Type 2, various... Read More
